Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
29
2020
New York Legislature Passes Bill to Ban PFAS in Food Packaging Keller and Heckman LLP
Jul
28
2020
FDA Issues Draft Guidance on Cannabis Clinical Research and Sends CBD Enforcement Discretion Guidance to OMB for Review Epstein Becker & Green, P.C.
Jul
28
2020
Florida Supreme Court Requests Additional Oral Argument in Major Medical Marijuana Licensure Case Greenberg Traurig, LLP
Jul
28
2020
Japan Proposes Revisions to Positive List for Food-Contact Resins Keller and Heckman LLP
Jul
28
2020
CBD: Sometimes It Can Be Legal but Still “Unlawful” Squire Patton Boggs (US) LLP
Jul
27
2020
President Trump Signs Drug Pricing Executive Orders Reinforcing the Administration's Priorities K&L Gates
Jul
27
2020
A Shot Across the Bow of the Pharmaceutical Industry: President Trump Issues a Quartet of Executive Orders on Drug Pricing that Might Eventually (OR NEVER?) Take Effect Sheppard, Mullin, Richter & Hampton LLP
Jul
27
2020
COVID-19 Food & Beverage Regulatory Updates Foley & Lardner LLP
Jul
27
2020
In Response to COVID-19, FDA Extends Enforcement Discretion for HCT/Ps Requiring Pre-Market Review Epstein Becker & Green, P.C.
Jul
27
2020
AMS Proposes to Add “Sugarcane (Insect Resistant)” to the List of Bioengineered Foods Subject to Disclosure Under the National Bioengineered Food Disclosure Standard Keller and Heckman LLP
Jul
25
2020
Trump Administration Releases Series of Executive Orders on Drug Pricing Mintz
Jul
24
2020
Sixth Circuit Panel Dismisses Motion to Enforce Writ of Mandamus Squire Patton Boggs (US) LLP
Jul
24
2020
No “White” Lie: Plaintiffs Fail to Show Reasonable Consumer Would Expect “White Morsels” to Contain White Chocolate Proskauer Rose LLP
Jul
24
2020
Can Percentages be Rounded in Relative Nutrient Content Claims? Keller and Heckman LLP
Jul
24
2020
FDA Issues Final Compliance Policy Guide on the Use of The Seafood List to Determine Acceptable Seafood Names Keller and Heckman LLP
Jul
23
2020
COVID-19: FDA Clears Path for Test to Screen Asymptomatic Individuals Foley & Lardner LLP
Jul
23
2020
FDA Announces Qualified Health Claim for Certain Cranberry Products and Urinary Tract Infections Keller and Heckman LLP
Jul
23
2020
A Legen-dairy Victory: Ben & Jerry’s Wins “Happy Cows” False Advertising Lawsuit Proskauer Rose LLP
Jul
23
2020
K&L Gates Triage: Recent Developments in the 340B Drug Pricing Program [Podcast] K&L Gates
Jul
22
2020
Ohio Case Will Likely Determine Whether Other States Use 21st Amendment Enforcement Act McDermott Will & Emery
Jul
22
2020
New FDA Draft Guidance Clarifies Cannabis-Related Clinical Research Requirements Keller and Heckman LLP
Jul
21
2020
Senators Announce Bipartisan Bill Requiring Pharmaceutical Supply Chain Report Squire Patton Boggs (US) LLP
Jul
21
2020
340b Update: HRSA Indicates It Lacks Authority to Enforce 340b Program Guidance K&L Gates
Jul
21
2020
Elmiron Litigation Continues: What they still aren’t telling you… Stark & Stark
Jul
21
2020
FDA Adds Five New Substances to its Inventory of Effective FCS Notifications 2020 Keller and Heckman LLP
Jul
21
2020
FTC PrivacyCon 2020: Health Apps Area of FTC Focus Going Forward Squire Patton Boggs (US) LLP
Jul
21
2020
Colombia Proposes New Chemical Regulatory Framework, Comments Due July 31, 2020 Beveridge & Diamond PC
Jul
21
2020
Further Update on FDA’s Comprehensive Regenerative Medicine Framework: November 2020 Deadline Extended by Six Months Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins